Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9480	Companies
185564	Keywords
117971	Articles
99400	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 07/01/2024 at 07:00, 1 year 5 months ago

Biophy(s a présenté les résultats de l'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris
Biophytis présente les résultats de l'étude COVA de phase 2-3 sur les formes sévères de Covid-19 lors du WCID à Paris. Des résultats positifs de réduction du risque de défaillance respiratoire et de mortalité sont révélés

Biophytis COVID-19 Résultats Positifs Étude COVA Réduction Du Risque De Mortalité
REGULATED PRESS RELEASE

published on 07/01/2024 at 07:00, 1 year 5 months ago

Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
Biophytis presented positive results of its Phase 2-3 COVA study for severe Covid-19 at WCID in Paris, showing reduction in respiratory failure and death rates

Biophytis COVID-19 Positive Results Phase 2-3 COVA Study
BRIEF

published on 06/25/2024 at 23:05, 1 year 5 months ago

Biophytis Approves All Resolutions at General Meeting

Shareholders Biophytis General Meeting Resolutions
BRIEF

published on 06/25/2024 at 23:05, 1 year 5 months ago

Résultats de l'Assemblée Générale Mixte de Biophytis du 24 juin 2024

Biophytis Assemblée Générale Resolutions Quorum Vote
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 1 year 5 months ago

RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
Biophytis SA announces the approval of all resolutions at the combined general meeting held on June 24, 2024, with significant shareholder participation

Shareholders General Meeting Resolutions Approval Biophytis SA
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 1 year 5 months ago

RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 JUIN 2024
Biophytis annonce l'approbation des résolutions lors de l'Assemblée Générale Mixte du 24 Juin 2024. Détails des décisions et perspectives de la société

Biophytis Biotechnologie Assemblée Générale Mixte Approbation Des Résolutions Développement De Traitements
BRIEF

published on 06/20/2024 at 07:05, 1 year 5 months ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine

Biophytis Partenariat Amérique Latine BIO101 Blanver
BRIEF

published on 06/20/2024 at 07:05, 1 year 5 months ago

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at Up to €108 Million

Biophytis Pharmaceuticals Latin America BIO101 Blanver
PRESS RELEASE

published on 06/20/2024 at 07:00, 1 year 5 months ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development

Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
PRESS RELEASE

published on 06/20/2024 at 07:00, 1 year 5 months ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€. Accord de licence exclusive pour la commercialisation de BIO101, y compris dans l’obésité et les infections respiratoires

Biophytis Accord BIO101 Blanver Am\u00e9rique Latine

Accesswire

Published on 12/06/2025 at 02:00, 4 hours 53 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 5 hours 38 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 6 hours 28 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 6 hours 53 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 7 hours 23 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 8 hours 37 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 8 hours 41 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 11 hours 55 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 12 hours 26 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 12 hours 38 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 7 hours 53 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 7 hours 53 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 7 hours 53 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 7 hours 53 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 13 hours 35 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE